Florida Cancer Specialists' Payer Strategy Chief Honored in 40 Under 40 in Cancer Awards
Event summary
- Kiana Mehring, SVP of payer strategy at Florida Cancer Specialists, received the 40 Under 40 in Cancer Award on May 30, 2026.
- Mehring leads payer contracting, value-based care models, and revenue cycle operations for FCS.
- FCS conducts over 180 active clinical trials annually through its research program with Sarah Cannon Research Institute.
- FCS has been a leader in providing early access to FDA-approved cancer drugs through clinical trials.
The big picture
Florida Cancer Specialists' recognition underscores the growing importance of payer collaboration in community oncology. As value-based care models gain traction, FCS's strategic alignment of payer contracting and revenue cycle operations positions it as a leader in sustainable, patient-centered cancer care. The company's robust clinical research program further solidifies its role in advancing oncology treatments.
What we're watching
- Value-Based Care Expansion
- How FCS's payer strategy initiatives will impact the adoption of value-based care models in community oncology.
- Regulatory Influence
- Whether Mehring's leadership in payer management will shape national policies on oncology care access.
- Clinical Trial Growth
- The pace at which FCS can expand its clinical trial offerings while maintaining high-quality patient care.
Related topics